This receptor cross-talk activates interleukin-11 (IL-11) expression and function, promoting the expression of pro-tumorigenic genes such as ITGA5 and ICAM-1, and enhancing the migratory and invasive features of patient-derived breast cancer-associated fibroblasts (CAFs) (90). Here, IL11 is linked to breast cancer.